Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat

被引:29
作者
Piepot, HA
Groeneveld, ABJ
van Lambalgen, AA
Sipkema, P
机构
[1] Free Univ Amsterdam, Med Intens Care Unit, NL-1081 HV Amsterdam, Netherlands
[2] Free Univ Amsterdam, Physiol Lab, NL-1081 HV Amsterdam, Netherlands
[3] Free Univ Amsterdam, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands
关键词
acetylcholine; regional differences in vascular reactivity; endotoxin shock; endothelial NO synthase; coronary endothelial function; infection;
D O I
10.1016/S0022-4804(02)00043-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Endotoxemia may result in endothelial dysfunction, and some vascular beds may be affected more than others. To test this hypothesis, we studied, in vitro, the reactivity of isolated rat coronary, renal, superior mesenteric, and hepatic arteries exposed to endotoxin (E. coli, 50 mug . mL(-1)) or saline for 2 h at 37degreesC. Vascular smooth muscle function was tested using 125 mM KCl, the vasoconstrictors norepinephrine (NE), and the thromboxane analog U46619 (coronary artery). Endothelium-dependent vasorelaxation was tested with acetylcholine (ACh) in preconstricted vessels. Although differing between vessel types, the smooth muscle contractile responses were not affected by endotoxin, either in the presence or absence of L-arginine. Endotoxin impaired the response to ACh in rat coronary arteries (92.7 +/- 4.6% vasodilation in control and 41.3 +/- 11.6% in endotoxin-exposed segments) and in renal arteries (66.7 +/- 5.2% vasodilation in control and 43.2 +/- 4.9% in endotoxin-exposed segments), so that there was a mean 55% decrease vs controls in coronary and a mean 35% decrease in renal arteries. Endotoxin did not affect superior mesenteric and hepatic arteries. Brief endotoxin exposure of isolated rat arteries may thus inactivate endothelial NO synthase, independent of iNOS. The increase in heterogeneity among endothelium-dependent vasodilation after endotoxin may help to explain early blood flow maldistribution in endotoxin shock. (C) 2003 Elsevier Science (USA).
引用
收藏
页码:413 / 418
页数:6
相关论文
共 35 条
[1]   Endothelial function and myocardial infarction [J].
Bhagat, K .
CARDIOVASCULAR RESEARCH, 1998, 39 (02) :312-317
[2]   Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia [J].
Bogle, RG ;
McLean, PG ;
Ahluwalia, A ;
Vallance, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :118-124
[3]   Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia [J].
Brandes, RP ;
Koddenberg, G ;
Gwinner, W ;
Kim, DY ;
Kruse, HJ ;
Busse, R ;
Mügge, A .
HYPERTENSION, 1999, 33 (05) :1243-1249
[4]   Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation [J].
Cannon, TR ;
Mann, GE ;
Baydoun, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (04) :637-644
[5]  
Clark SG, 1997, J PHARMACOL EXP THER, V282, P1473
[6]   Endotoxin-induced inhibition of mesenteric vasodilator responses to acetylcholine, bradykinin, and post-occlusion hyperemia in anesthetized rats [J].
FatehiHassanabad, Z ;
Parratt, JR ;
Furman, BL .
SHOCK, 1996, 6 (05) :371-376
[7]   ESCHERICHIA-COLI ENDOTOXIN INHIBITS AGONIST-MEDIATED CYTOSOLIC CA2+ MOBILIZATION AND NITRIC-OXIDE BIOSYNTHESIS IN CULTURED ENDOTHELIAL-CELLS [J].
GRAIER, WF ;
MYERS, PR ;
RUBIN, LJ ;
ADAMS, HR ;
PARKER, JL .
CIRCULATION RESEARCH, 1994, 75 (04) :659-668
[8]  
GROENEVELD ABJ, 2001, YB INTENSIVE CARE EM, P221
[9]   Acute systemic inflammation impairs endothelium-dependent dilatation in humans [J].
Hingorani, AD ;
Cross, J ;
Kharbanda, RK ;
Mullen, MJ ;
Bhagat, K ;
Taylor, M ;
Donald, AE ;
Palacios, M ;
Griffin, GE ;
Deanfield, JE ;
MacAllister, RJ ;
Vallance, P .
CIRCULATION, 2000, 102 (09) :994-999
[10]   The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin [J].
Hohlfeld, T ;
Klemm, P ;
Thiemermann, C ;
Warner, TD ;
Schror, K ;
Vane, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (08) :3309-3315